Investigating the impact of omega-3 fatty acids on COPD outcomes
OMEGA COPD Trial
['FUNDING_R01'] · JOHNS HOPKINS UNIVERSITY · NIH-10909883
The OMEGA COPD Trial is looking at how eating more omega-3 fatty acids might help people with COPD, especially those in low-income communities, by improving their breathing and health while also considering the effects of indoor air pollution.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | JOHNS HOPKINS UNIVERSITY (nih funded) |
| Locations | 1 site (BALTIMORE, UNITED STATES) |
| Trial ID | NIH-10909883 on ClinicalTrials.gov |
What this research studies
The OMEGA COPD Trial focuses on understanding how dietary intake of omega-3 polyunsaturated fatty acids affects individuals with chronic obstructive pulmonary disease (COPD), particularly in low-income communities. The research aims to assess the relationship between low omega-3 intake and adverse respiratory outcomes, while also considering the impact of indoor air pollution on these patients. Participants may receive dietary interventions designed to increase omega-3 intake, which could help improve their respiratory health and overall well-being.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who have been diagnosed with COPD, particularly those from low-income communities.
Not a fit: Patients with COPD who already have adequate omega-3 intake or those who do not meet the age criteria may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved dietary recommendations and interventions that enhance respiratory health for patients with COPD.
How similar studies have performed: Previous research has indicated that dietary modifications, particularly increasing omega-3 intake, can positively influence respiratory health, suggesting a promising avenue for this trial.
Where this research is happening
BALTIMORE, UNITED STATES
- JOHNS HOPKINS UNIVERSITY — BALTIMORE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HANSEL, NADIA N — JOHNS HOPKINS UNIVERSITY
- Study coordinator: HANSEL, NADIA N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.